David Norval
About David Norval
David Norval is the Director of Biometrics at Aimmune Therapeutics in London, United Kingdom, a position he has held since 2017. He previously worked as a Senior Consultant in Biostatistics at Cmed Clinical Services and as Head of Biometrics at Silence Therapeutics plc.
Work at Aimmune Therapeutics
David Norval has served as the Director of Biometrics at Aimmune Therapeutics since 2017. In this role, he oversees biometrics operations within the European region, contributing to the company's focus on developing treatments for food allergies. His responsibilities include managing statistical analysis and data management, ensuring compliance with regulatory standards, and facilitating collaboration among cross-functional teams. His tenure at Aimmune Therapeutics has spanned over seven years, during which he has played a key role in advancing the company's clinical development initiatives.
Previous Experience at Cmed Clinical Services
Prior to his current position, David Norval worked at Cmed Clinical Services as a Senior Consultant in Biostatistics from 2012 to 2013. His role involved providing statistical expertise and support for clinical trials, contributing to the design and analysis of study data. This experience enhanced his skills in biostatistics and solidified his understanding of the clinical research landscape.
Role at Silence Therapeutics plc
David Norval held the position of Head of Biometrics at Silence Therapeutics plc from 2014 to 2015. In this capacity, he was responsible for leading the biometrics team, focusing on statistical analysis and data management for clinical trials. His leadership in this role contributed to the company's efforts in advancing innovative therapeutic solutions.
Education and Expertise
David Norval earned a Bachelor of Science degree in Statistics from The University of Glasgow, where he studied from 1983 to 1987. His academic background in statistics provides a strong foundation for his work in biostatistics and clinical research. This educational experience has equipped him with the analytical skills necessary to navigate complex data sets and contribute effectively to clinical trial design and analysis.